2024 PACC Miami | Clinical Review of Tarlatamab-dlle, The First Bispecific T-Cell Engager (BiTE) Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer
0% Complete
Course Content
This material is non-CME, no credits are available, and a certificate will not be provided upon completion.
Course Details
- Duration
- 0.00 hour
- Released
- May 14, 2025
- Last Review
- May 14, 2025
- Expires
- May 14, 2028
Faculty & Disclosure
Faculty
Khurrum Qureshi, PharmD, BCOP
Disclosure
Khurrum Qureshi, PharmD, BCOP discloses no such relationships exist
Accreditation
NA
